Treatment of skin injury due to vinorelbine extravasation using bFGF and rhGM-CSF: An experimental study in a murine model

Biological Research for Nursing

Volumn 13, Issue 1, 2011, Pages 32-37

  Yu, Chunhua ^a   Wang, Jin ^a   Fu, Yan ^a   Mao, Yongqiu ^a   Chen, Yongshun ^a   Jiang, Yongdong ^a   Liao, Xuejuan ^a   Guo, Juhong ^a   Xu, Qiong ^a   Li, Junying ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

bFGF; extravasation; murine model; rhGM CSF; vinorelbine

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NAVELBINE; RECOMBINANT PROTEIN; VINBLASTINE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CONTRAST MEDIUM EXTRAVASATION; DISEASE MODEL; DRUG EFFECT; EDEMA; FEMALE; HUMAN; MALE; MOUSE; MOUSE STRAIN; PATHOLOGY; SKIN; SKIN ULCER; WOUND HEALING;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DISEASE MODELS, ANIMAL; EDEMA; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MICE; MICE, INBRED STRAINS; RECOMBINANT PROTEINS; SKIN; SKIN ULCER; VINBLASTINE; WOUND HEALING;

EID: 78650792273     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800410378160     Document Type: Article

References (24)

1. Akita, S., Akino, K., Imaizumi, T., & Hirano, A. (2005). A basic fibroblast growth factor improved the quality of skin grafting in burn patients. Burns, 31, 855-858.
2. Bhora, F.Y., Dunkin, B.J., Batzri, S., Aly, H.M., Bass, B.L., Sidawy, A.N., & Harmon, J.W. (1995). Effect of growth factors on cell proliferation and epithelialization in human skin. Journal of Surgical Research, 59, 236-244.
3. Broadley, K.N., Aquino, A.M., Woodward, S.C., Buckley-Sturrock, A., Sato, Y., Rifkin, D.B., & Davidson, J.M. (1989). Monospecific antibodies implicate basic fibroblast growth factor in normal wound repair. Laboratory Investigation, 61, 571-575.
4. Brogden, J.M., & Nevidjon, B. (1995). Vinorelbine (Navelbine), drug profile and nursing implication of a new vinca alkaloid. Oncology Nursing Forum, 22, 46-48.
5. Cicchetti, S., Jemec, B., & Gault, D.T. (2000). Two case reports of vinorelbine extravasation: Management and review of the literature. Tumor, 86, 289-292.
6. Deindl, E., Hoefer, I.E., Fernandez, B., Barancik, M., Heil, M., Strniskova, M., & Schaper, W. (2003). Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogenesis. Circulation Research, 92, 561-568.
7. Dorr, R.T., & Alberts, D.S. (1985). Vinca alkaloid skin toxicity: Antidote and drug disposition studies in the mouse. Journal of the National Cancer Institute, 74, 113-120.
8. Gilbar, P.J., & Carrington, C.V. (2006). The incidence of extravasation of vinca alkaloids supplied in syringes or mini-bags. Journal of Oncology Pharmacy Practice, 12, 113-118.
9. Gridelli, S. (2001). The ELVIS trial: A phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Oncologist, 6, 4-7.
10. Hashimoto, T., Koyama, H., Miyata, T., Hosaka, A., Tabata, Y., Takato, T., & Nagawa, H. (2009). Selective and sustained delivery of basic fibroblast growth factor (bFGF) for treatment of peripheral arterial disease: Results of a Phase I trial. European Journal of Vascular and Endovascular Surgery, 38, 71-75.
11. Jiang, W., Wang, H.L., Jin, F.G., Yu, C.Y., Chu, D.L., Wang, L., & Lu, X. (2008). Improved wound healing in pressure-induced decubitus ulcer with controlled release of basic fibroblast growth factor. Journal of Alloys and Compounds, 459, 508-514.
12. Kawai, K., Suzuki, S., Tabata, Y., & Nishimura, Y. (2005). Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. British Journal of Plastic Surgery, 58, 1115-1123.
13. Kurokawa, I., Havami, J., & Kita, Y. (2003). A therapy-resistant chronic leg ulcer treated successfully with topical basic fibroblast growth factor. Journal of International Medical Research, 31, 149-151.
14. Langstein, H.N., Duman, H., Seelig, D., Butler, C.E., & Evans, G.R. (2002). Retrospective study of the management of chemotherapeutic extravasation injury. Annals of Plastic Surgery, 49, 369-374.
15. Linder, R.M., Upton, J., & Osteen, R. (1983). Management of extensive doxorubicin hydrochloride extravasation injuries. Journal of Hand Surgery, 8, 33.
16. Moreno de Vega, M.J., Dauden, E., Abajo, P., Bartolome, B., Fraga, J., & Garcia-Diez, A. (2002). Skin necrosis from extravasation of vinorelbine. Journal of the European Academy of Dermatology and Venereology, 16, 488-490.
17. Park, C.J., Clark, S.G., Lichtensteiger, C.A., Jamison, R.D., & Wagoner Johnson, A.J. (2009). Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. Acta Biomaterialia, 5, 1926-1936.
18. Seidman, C., Raffetto, J.D., Overman, K.C., & Menzoian, J.O. (2006). Venous ulcer fibroblasts respond to basic fibroblast growth factor at the cell cycle protein level. Annals of Vascular Surgery, 20, 376-380.
19. Takiqawa, N., & Tanimoto, M. (2008). Vinca alkaloid and MDR1. Gan To Kaqaku Ryoho, 35, 1086-1089.
20. Tiede, S., Ernst, N., Bayat, A., Paus, R., Tronnier, V., & Zechel, C. (2009). Basic fibroblast growth factor: A potential new therapeutic tool for the treatment of hypertrophic and keloid scars. Annals of Anatomy, 191, 33-44.
21. Vargel, I., Erdem, A., Ertoy, D., Pinar, A., Erk, Y., Altundag, M.K., & Gullu, I. (2002). Effects of growth factor on doxorubicin-induced skin necrosis: Documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF. Annals of Plastic Surgery, 49, 646-653.
22. Waller, E.K. (2007). The role of sargramostim (rhGM-CSF) as immunotherapy. Oncologist, 12, 22-26.
23. Wengstrom, Y., & Margulies, A. (2008). European Oncology Nursing Society extravasation guidelines. European Journal of Oncology Nursing, 12, 357-361.
24. Zelek, L., Barthier, S., Riofrio, M., Fizazi, K., Rixe, O., Delord, J.P., & Spielmann, M. (2001). Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma. Cancer, 92, 2267-2272.